Latest Oncolytic virus Stories
In a research study appearing in the journal Cancer Cell on March 14, scientists from Cold Spring Harbor Laboratory (CSHL) and four other institutions have identified a strategy for targeted molecular therapy in liver cancer, which currently has limited treatment options and one of the worst one-year survival rates of any cancer type.
CALGARY, Feb. 23 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX: ONC) (NASDAQ: ONCY) announced today that enrollment has been completed in a U.K.
SAN FRANCISCO, Feb. 22, 2011 /PRNewswire/ -- Jennerex, Inc. (San Francisco), a clinical-stage cancer biotherapeutics company, today announced the appointment of James M. Burke, M.D. to the newly-created position of vice president, clinical research. Dr.
HELSINKI, February 9, 2011 /PRNewswire/ -- Oncos Therapeutics, a biotech company developing novel cancer therapeutics based on its next generation oncolytic viruses, announced today the appointment of Dr. Mikael von Euler, MD, PhD, FFPM, as Chief Medical Officer.
SAN FRANCISCO, Jan. 19, 2011 /PRNewswire/ -- Jennerex, Inc.
New research shows that oncolytic viruses, which are engineered to destroy cancer cells, might be more effective in treating deadly brain tumors if equipped with an enzyme that helps them penetrate the tumor.
Scientists at IRB Barcelona have discovered that some brain tumours in larvae of the fruit fly Drosophila melanogaster use the genetic programme of germline cells to grow.
SAN FRANCISCO and ILLKIRCH, France, Dec.
Researchers at the University of Cambridge hope to revolutionise cancer therapy after discovering one of the reasons why many previous attempts to harness the immune system to treat cancerous tumours have failed.
CALGARY, Oct. 26 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.
- A gift; a largess; a gratuity; a present; a dole.